nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—DNMT1—brain cancer	0.8	1	CbGaD
Procainamide—SCN8A—cerebellar cortex—brain cancer	0.00908	0.0976	CbGeAlD
Procainamide—CYP2D6—Lomustine—brain cancer	0.00835	0.569	CbGbCtD
Procainamide—CYP2D6—Hydroxyurea—brain cancer	0.00633	0.431	CbGbCtD
Procainamide—SCN11A—ganglion—brain cancer	0.00434	0.0466	CbGeAlD
Procainamide—Pericarditis—Procarbazine—brain cancer	0.00337	0.0481	CcSEcCtD
Procainamide—Lupus erythematosus—Hydroxyurea—brain cancer	0.00303	0.0432	CcSEcCtD
Procainamide—SCN8A—hindbrain—brain cancer	0.00249	0.0268	CbGeAlD
Procainamide—SCN10A—ganglion—brain cancer	0.0022	0.0236	CbGeAlD
Procainamide—Systemic lupus erythematosus—Hydroxyurea—brain cancer	0.00204	0.0291	CcSEcCtD
Procainamide—Sunitinib—DAPK1—brain cancer	0.00202	0.314	CrCbGaD
Procainamide—Pleural effusion—Procarbazine—brain cancer	0.00191	0.0272	CcSEcCtD
Procainamide—SCN1A—hindbrain—brain cancer	0.00188	0.0203	CbGeAlD
Procainamide—SCN2A—hindbrain—brain cancer	0.00173	0.0186	CbGeAlD
Procainamide—Lethargy—Lomustine—brain cancer	0.0017	0.0243	CcSEcCtD
Procainamide—SLC22A1—ganglion—brain cancer	0.00167	0.018	CbGeAlD
Procainamide—SCN8A—brainstem—brain cancer	0.00143	0.0154	CbGeAlD
Procainamide—SCN8A—telencephalon—brain cancer	0.00127	0.0136	CbGeAlD
Procainamide—Renal failure—Lomustine—brain cancer	0.00126	0.018	CcSEcCtD
Procainamide—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00119	0.017	CcSEcCtD
Procainamide—Haemolytic anaemia—Procarbazine—brain cancer	0.00117	0.0167	CcSEcCtD
Procainamide—SCN11A—spinal cord—brain cancer	0.00117	0.0126	CbGeAlD
Procainamide—DNMT1—telencephalon—brain cancer	0.00109	0.0117	CbGeAlD
Procainamide—Lethargy—Procarbazine—brain cancer	0.00108	0.0154	CcSEcCtD
Procainamide—SCN1A—brainstem—brain cancer	0.00108	0.0116	CbGeAlD
Procainamide—SCN11A—head—brain cancer	0.00104	0.0112	CbGeAlD
Procainamide—Rash maculo-papular—Hydroxyurea—brain cancer	0.00103	0.0146	CcSEcCtD
Procainamide—Sunitinib—ALK—brain cancer	0.00101	0.158	CrCbGaD
Procainamide—SCN2A—brainstem—brain cancer	0.000991	0.0107	CbGeAlD
Procainamide—Moclobemide—CYP2C9—brain cancer	0.000989	0.154	CrCbGaD
Procainamide—SCN1A—telencephalon—brain cancer	0.000959	0.0103	CbGeAlD
Procainamide—SCN11A—central nervous system—brain cancer	0.000951	0.0102	CbGeAlD
Procainamide—Hepatic enzyme increased—Temozolomide—brain cancer	0.000933	0.0133	CcSEcCtD
Procainamide—Hepatic failure—Hydroxyurea—brain cancer	0.000912	0.013	CcSEcCtD
Procainamide—DNMT1—gonad—brain cancer	0.000912	0.0098	CbGeAlD
Procainamide—SCN9A—pituitary gland—brain cancer	0.000907	0.00975	CbGeAlD
Procainamide—Eosinophilia—Procarbazine—brain cancer	0.000907	0.0129	CcSEcCtD
Procainamide—SCN7A—endocrine gland—brain cancer	0.000897	0.00964	CbGeAlD
Procainamide—DNMT1—pituitary gland—brain cancer	0.00089	0.00956	CbGeAlD
Procainamide—SCN8A—spinal cord—brain cancer	0.000889	0.00955	CbGeAlD
Procainamide—ACHE—telencephalon—brain cancer	0.000888	0.00954	CbGeAlD
Procainamide—SCN7A—head—brain cancer	0.000886	0.00952	CbGeAlD
Procainamide—SCN2A—telencephalon—brain cancer	0.00088	0.00945	CbGeAlD
Procainamide—DNMT1—medulla oblongata—brain cancer	0.000859	0.00923	CbGeAlD
Procainamide—SCN10A—telencephalon—brain cancer	0.000848	0.00912	CbGeAlD
Procainamide—Sunitinib—PDGFRA—brain cancer	0.000817	0.127	CrCbGaD
Procainamide—SCN4A—pituitary gland—brain cancer	0.000809	0.0087	CbGeAlD
Procainamide—Thrombocytopenia—Lomustine—brain cancer	0.000803	0.0114	CcSEcCtD
Procainamide—SCN9A—midbrain—brain cancer	0.0008	0.0086	CbGeAlD
Procainamide—SCN8A—endocrine gland—brain cancer	0.0008	0.0086	CbGeAlD
Procainamide—SCN8A—head—brain cancer	0.00079	0.00849	CbGeAlD
Procainamide—DNMT1—midbrain—brain cancer	0.000785	0.00843	CbGeAlD
Procainamide—Anorexia—Lomustine—brain cancer	0.000782	0.0111	CcSEcCtD
Procainamide—SCN9A—spinal cord—brain cancer	0.000781	0.00839	CbGeAlD
Procainamide—SCN3A—telencephalon—brain cancer	0.000773	0.00831	CbGeAlD
Procainamide—DNMT1—spinal cord—brain cancer	0.000766	0.00823	CbGeAlD
Procainamide—SCN11A—brain—brain cancer	0.000755	0.00811	CbGeAlD
Procainamide—SCN1A—medulla oblongata—brain cancer	0.000753	0.00809	CbGeAlD
Procainamide—Body temperature increased—Carboplatin—brain cancer	0.000741	0.0106	CcSEcCtD
Procainamide—Hallucination—Procarbazine—brain cancer	0.000729	0.0104	CcSEcCtD
Procainamide—SCN8A—central nervous system—brain cancer	0.000721	0.00775	CbGeAlD
Procainamide—SCN2A—pituitary gland—brain cancer	0.000716	0.0077	CbGeAlD
Procainamide—Decreased appetite—Lomustine—brain cancer	0.000713	0.0102	CcSEcCtD
Procainamide—Hepatic failure—Temozolomide—brain cancer	0.000713	0.0102	CcSEcCtD
Procainamide—SCN8A—cerebellum—brain cancer	0.000705	0.00757	CbGeAlD
Procainamide—ACHE—medulla oblongata—brain cancer	0.000698	0.0075	CbGeAlD
Procainamide—SCN2A—medulla oblongata—brain cancer	0.000691	0.00743	CbGeAlD
Procainamide—SCN10A—pituitary gland—brain cancer	0.000691	0.00742	CbGeAlD
Procainamide—DNMT1—endocrine gland—brain cancer	0.000689	0.00741	CbGeAlD
Procainamide—SCN1A—midbrain—brain cancer	0.000688	0.0074	CbGeAlD
Procainamide—DNMT1—head—brain cancer	0.000681	0.00731	CbGeAlD
Procainamide—Flushing—Procarbazine—brain cancer	0.00068	0.0097	CcSEcCtD
Procainamide—SCN1A—spinal cord—brain cancer	0.000672	0.00722	CbGeAlD
Procainamide—Neutropenia—Hydroxyurea—brain cancer	0.000663	0.00945	CcSEcCtD
Procainamide—Chills—Procarbazine—brain cancer	0.000658	0.00938	CcSEcCtD
Procainamide—CHRM2—telencephalon—brain cancer	0.000656	0.00705	CbGeAlD
Procainamide—Body temperature increased—Lomustine—brain cancer	0.000648	0.00924	CcSEcCtD
Procainamide—SLC22A1—telencephalon—brain cancer	0.000645	0.00693	CbGeAlD
Procainamide—SCN7A—brain—brain cancer	0.000642	0.0069	CbGeAlD
Procainamide—Rash maculo-papular—Etoposide—brain cancer	0.000642	0.00915	CcSEcCtD
Procainamide—ACHE—midbrain—brain cancer	0.000638	0.00685	CbGeAlD
Procainamide—SCN2A—midbrain—brain cancer	0.000632	0.00679	CbGeAlD
Procainamide—SCN3A—pituitary gland—brain cancer	0.00063	0.00677	CbGeAlD
Procainamide—ACHE—spinal cord—brain cancer	0.000622	0.00669	CbGeAlD
Procainamide—DNMT1—central nervous system—brain cancer	0.000621	0.00668	CbGeAlD
Procainamide—SCN4A—head—brain cancer	0.000619	0.00665	CbGeAlD
Procainamide—SCN2A—spinal cord—brain cancer	0.000616	0.00662	CbGeAlD
Procainamide—SCN3A—medulla oblongata—brain cancer	0.000608	0.00653	CbGeAlD
Procainamide—DNMT1—cerebellum—brain cancer	0.000607	0.00652	CbGeAlD
Procainamide—SCN1A—head—brain cancer	0.000597	0.00641	CbGeAlD
Procainamide—SCN10A—spinal cord—brain cancer	0.000594	0.00639	CbGeAlD
Procainamide—SCN8A—brain—brain cancer	0.000572	0.00615	CbGeAlD
Procainamide—CYP2D6—hindbrain—brain cancer	0.000568	0.00611	CbGeAlD
Procainamide—SCN4A—central nervous system—brain cancer	0.000565	0.00607	CbGeAlD
Procainamide—Hallucination—Hydroxyurea—brain cancer	0.000564	0.00805	CcSEcCtD
Procainamide—SCN3A—midbrain—brain cancer	0.000555	0.00597	CbGeAlD
Procainamide—Lidocaine—EGFR—brain cancer	0.000555	0.0864	CrCbGaD
Procainamide—SCN2A—endocrine gland—brain cancer	0.000555	0.00596	CbGeAlD
Procainamide—Convulsion—Procarbazine—brain cancer	0.000553	0.00788	CcSEcCtD
Procainamide—SLC22A4—pituitary gland—brain cancer	0.000551	0.00592	CbGeAlD
Procainamide—SCN2A—head—brain cancer	0.000548	0.00589	CbGeAlD
Procainamide—SCN1A—central nervous system—brain cancer	0.000545	0.00586	CbGeAlD
Procainamide—Arthralgia—Procarbazine—brain cancer	0.000543	0.00774	CcSEcCtD
Procainamide—Myalgia—Procarbazine—brain cancer	0.000543	0.00774	CcSEcCtD
Procainamide—SCN3A—spinal cord—brain cancer	0.000542	0.00582	CbGeAlD
Procainamide—Neutropenia—Carmustine—brain cancer	0.000536	0.00764	CcSEcCtD
Procainamide—SCN10A—endocrine gland—brain cancer	0.000535	0.00575	CbGeAlD
Procainamide—SCN1A—cerebellum—brain cancer	0.000533	0.00572	CbGeAlD
Procainamide—SCN10A—head—brain cancer	0.000528	0.00568	CbGeAlD
Procainamide—Probenecid—CYP2C9—brain cancer	0.000527	0.0819	CrCbGaD
Procainamide—Cardiac failure—Etoposide—brain cancer	0.000525	0.00749	CcSEcCtD
Procainamide—Confusional state—Procarbazine—brain cancer	0.000525	0.00748	CcSEcCtD
Procainamide—Vomiting—Lomustine—brain cancer	0.000521	0.00743	CcSEcCtD
Procainamide—Neutropenia—Temozolomide—brain cancer	0.000518	0.00738	CcSEcCtD
Procainamide—SLC22A3—gonad—brain cancer	0.000514	0.00553	CbGeAlD
Procainamide—Shock—Procarbazine—brain cancer	0.000512	0.0073	CcSEcCtD
Procainamide—Thrombocytopenia—Procarbazine—brain cancer	0.00051	0.00727	CcSEcCtD
Procainamide—Depression—Carmustine—brain cancer	0.000509	0.00726	CcSEcCtD
Procainamide—Chills—Hydroxyurea—brain cancer	0.000509	0.00726	CcSEcCtD
Procainamide—Lidocaine—CYP2C9—brain cancer	0.000506	0.0788	CrCbGaD
Procainamide—SCN9A—brain—brain cancer	0.000503	0.0054	CbGeAlD
Procainamide—Renal failure—Carmustine—brain cancer	0.000502	0.00716	CcSEcCtD
Procainamide—SCN2A—central nervous system—brain cancer	0.0005	0.00537	CbGeAlD
Procainamide—Anorexia—Procarbazine—brain cancer	0.000496	0.00708	CcSEcCtD
Procainamide—ACHE—cerebellum—brain cancer	0.000493	0.0053	CbGeAlD
Procainamide—DNMT1—brain—brain cancer	0.000493	0.0053	CbGeAlD
Procainamide—Depression—Temozolomide—brain cancer	0.000492	0.00702	CcSEcCtD
Procainamide—BCHE—brainstem—brain cancer	0.000492	0.00528	CbGeAlD
Procainamide—SCN2A—cerebellum—brain cancer	0.000489	0.00525	CbGeAlD
Procainamide—Cardiac arrest—Etoposide—brain cancer	0.000487	0.00695	CcSEcCtD
Procainamide—Nausea—Lomustine—brain cancer	0.000487	0.00695	CcSEcCtD
Procainamide—Hypotension—Procarbazine—brain cancer	0.000487	0.00694	CcSEcCtD
Procainamide—SCN10A—central nervous system—brain cancer	0.000482	0.00518	CbGeAlD
Procainamide—SCN3A—head—brain cancer	0.000482	0.00517	CbGeAlD
Procainamide—SCN5A—head—brain cancer	0.00048	0.00516	CbGeAlD
Procainamide—SLC22A4—spinal cord—brain cancer	0.000474	0.0051	CbGeAlD
Procainamide—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000474	0.00676	CcSEcCtD
Procainamide—Ill-defined disorder—Hydroxyurea—brain cancer	0.000458	0.00653	CcSEcCtD
Procainamide—Hallucination—Carmustine—brain cancer	0.000456	0.0065	CcSEcCtD
Procainamide—Decreased appetite—Procarbazine—brain cancer	0.000453	0.00645	CcSEcCtD
Procainamide—SCN4A—brain—brain cancer	0.000449	0.00482	CbGeAlD
Procainamide—Malaise—Hydroxyurea—brain cancer	0.000445	0.00635	CcSEcCtD
Procainamide—Hallucination—Temozolomide—brain cancer	0.000441	0.00629	CcSEcCtD
Procainamide—SCN3A—central nervous system—brain cancer	0.00044	0.00472	CbGeAlD
Procainamide—SCN5A—central nervous system—brain cancer	0.000438	0.00471	CbGeAlD
Procainamide—BCHE—telencephalon—brain cancer	0.000436	0.00469	CbGeAlD
Procainamide—SCN1A—brain—brain cancer	0.000433	0.00465	CbGeAlD
Procainamide—SCN3A—cerebellum—brain cancer	0.00043	0.00462	CbGeAlD
Procainamide—Feeling abnormal—Procarbazine—brain cancer	0.000429	0.00612	CcSEcCtD
Procainamide—Convulsion—Hydroxyurea—brain cancer	0.000428	0.0061	CcSEcCtD
Procainamide—Gastrointestinal pain—Procarbazine—brain cancer	0.000426	0.00607	CcSEcCtD
Procainamide—Flushing—Carmustine—brain cancer	0.000426	0.00607	CcSEcCtD
Procainamide—Discomfort—Hydroxyurea—brain cancer	0.000415	0.00592	CcSEcCtD
Procainamide—Neutropenia—Etoposide—brain cancer	0.000414	0.00591	CcSEcCtD
Procainamide—CHRM2—endocrine gland—brain cancer	0.000414	0.00445	CbGeAlD
Procainamide—Urticaria—Procarbazine—brain cancer	0.000414	0.0059	CcSEcCtD
Procainamide—Body temperature increased—Procarbazine—brain cancer	0.000412	0.00587	CcSEcCtD
Procainamide—Abdominal pain—Procarbazine—brain cancer	0.000412	0.00587	CcSEcCtD
Procainamide—Cardiac disorder—Temozolomide—brain cancer	0.000411	0.00586	CcSEcCtD
Procainamide—Flushing—Temozolomide—brain cancer	0.000411	0.00586	CcSEcCtD
Procainamide—CHRM2—head—brain cancer	0.000409	0.00439	CbGeAlD
Procainamide—SLC22A1—endocrine gland—brain cancer	0.000407	0.00437	CbGeAlD
Procainamide—SLC22A1—head—brain cancer	0.000401	0.00431	CbGeAlD
Procainamide—ACHE—brain—brain cancer	0.000401	0.00431	CbGeAlD
Procainamide—Chills—Temozolomide—brain cancer	0.000398	0.00567	CcSEcCtD
Procainamide—SCN2A—brain—brain cancer	0.000397	0.00427	CbGeAlD
Procainamide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000395	0.00562	CcSEcCtD
Procainamide—SLC22A3—endocrine gland—brain cancer	0.000389	0.00418	CbGeAlD
Procainamide—Renal failure—Etoposide—brain cancer	0.000388	0.00554	CcSEcCtD
Procainamide—Anorexia—Hydroxyurea—brain cancer	0.000384	0.00548	CcSEcCtD
Procainamide—SLC22A3—head—brain cancer	0.000384	0.00412	CbGeAlD
Procainamide—Hypersensitivity—Procarbazine—brain cancer	0.000384	0.00547	CcSEcCtD
Procainamide—SCN10A—brain—brain cancer	0.000383	0.00411	CbGeAlD
Procainamide—Dysgeusia—Temozolomide—brain cancer	0.000378	0.00539	CcSEcCtD
Procainamide—SLC22A4—cerebellum—brain cancer	0.000376	0.00404	CbGeAlD
Procainamide—Asthenia—Procarbazine—brain cancer	0.000374	0.00533	CcSEcCtD
Procainamide—CHRM2—central nervous system—brain cancer	0.000373	0.00401	CbGeAlD
Procainamide—Agranulocytosis—Etoposide—brain cancer	0.000369	0.00525	CcSEcCtD
Procainamide—Pruritus—Procarbazine—brain cancer	0.000368	0.00525	CcSEcCtD
Procainamide—SLC22A1—central nervous system—brain cancer	0.000366	0.00394	CbGeAlD
Procainamide—SLC22A5—pituitary gland—brain cancer	0.000365	0.00392	CbGeAlD
Procainamide—Ill-defined disorder—Temozolomide—brain cancer	0.000358	0.0051	CcSEcCtD
Procainamide—Diarrhoea—Procarbazine—brain cancer	0.000356	0.00508	CcSEcCtD
Procainamide—BCHE—pituitary gland—brain cancer	0.000355	0.00382	CbGeAlD
Procainamide—Angioedema—Temozolomide—brain cancer	0.000352	0.00502	CcSEcCtD
Procainamide—SLC22A5—medulla oblongata—brain cancer	0.000352	0.00378	CbGeAlD
Procainamide—Decreased appetite—Hydroxyurea—brain cancer	0.00035	0.00499	CcSEcCtD
Procainamide—SLC22A3—central nervous system—brain cancer	0.00035	0.00376	CbGeAlD
Procainamide—SCN3A—brain—brain cancer	0.000349	0.00375	CbGeAlD
Procainamide—SCN5A—brain—brain cancer	0.000348	0.00374	CbGeAlD
Procainamide—Malaise—Temozolomide—brain cancer	0.000348	0.00496	CcSEcCtD
Procainamide—Convulsion—Carmustine—brain cancer	0.000346	0.00493	CcSEcCtD
Procainamide—Dizziness—Procarbazine—brain cancer	0.000344	0.00491	CcSEcCtD
Procainamide—BCHE—medulla oblongata—brain cancer	0.000343	0.00368	CbGeAlD
Procainamide—Myalgia—Carmustine—brain cancer	0.00034	0.00484	CcSEcCtD
Procainamide—Convulsion—Temozolomide—brain cancer	0.000334	0.00476	CcSEcCtD
Procainamide—Feeling abnormal—Hydroxyurea—brain cancer	0.000332	0.00473	CcSEcCtD
Procainamide—Vomiting—Procarbazine—brain cancer	0.000331	0.00472	CcSEcCtD
Procainamide—Flushing—Etoposide—brain cancer	0.000329	0.00469	CcSEcCtD
Procainamide—Cardiac disorder—Etoposide—brain cancer	0.000329	0.00469	CcSEcCtD
Procainamide—Confusional state—Carmustine—brain cancer	0.000328	0.00468	CcSEcCtD
Procainamide—Arthralgia—Temozolomide—brain cancer	0.000328	0.00468	CcSEcCtD
Procainamide—Myalgia—Temozolomide—brain cancer	0.000328	0.00468	CcSEcCtD
Procainamide—CYP2D6—brainstem—brain cancer	0.000326	0.0035	CbGeAlD
Procainamide—Discomfort—Temozolomide—brain cancer	0.000324	0.00463	CcSEcCtD
Procainamide—SLC22A5—midbrain—brain cancer	0.000322	0.00346	CbGeAlD
Procainamide—Thrombocytopenia—Carmustine—brain cancer	0.000319	0.00455	CcSEcCtD
Procainamide—Body temperature increased—Hydroxyurea—brain cancer	0.000319	0.00454	CcSEcCtD
Procainamide—Chills—Etoposide—brain cancer	0.000318	0.00454	CcSEcCtD
Procainamide—Confusional state—Temozolomide—brain cancer	0.000317	0.00453	CcSEcCtD
Procainamide—SLC22A5—spinal cord—brain cancer	0.000314	0.00337	CbGeAlD
Procainamide—BCHE—midbrain—brain cancer	0.000313	0.00337	CbGeAlD
Procainamide—Anorexia—Carmustine—brain cancer	0.000311	0.00443	CcSEcCtD
Procainamide—Nausea—Procarbazine—brain cancer	0.000309	0.00441	CcSEcCtD
Procainamide—Thrombocytopenia—Temozolomide—brain cancer	0.000308	0.00439	CcSEcCtD
Procainamide—BCHE—spinal cord—brain cancer	0.000306	0.00329	CbGeAlD
Procainamide—SLC22A4—brain—brain cancer	0.000306	0.00328	CbGeAlD
Procainamide—Hypotension—Carmustine—brain cancer	0.000304	0.00434	CcSEcCtD
Procainamide—Dysgeusia—Etoposide—brain cancer	0.000302	0.00431	CcSEcCtD
Procainamide—Anorexia—Temozolomide—brain cancer	0.0003	0.00428	CcSEcCtD
Procainamide—Hypersensitivity—Hydroxyurea—brain cancer	0.000297	0.00423	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Carmustine—brain cancer	0.000297	0.00423	CcSEcCtD
Procainamide—CHRM2—brain—brain cancer	0.000296	0.00318	CbGeAlD
Procainamide—SLC22A1—brain—brain cancer	0.000291	0.00313	CbGeAlD
Procainamide—CYP2D6—telencephalon—brain cancer	0.000289	0.00311	CbGeAlD
Procainamide—Asthenia—Hydroxyurea—brain cancer	0.000289	0.00412	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000287	0.00409	CcSEcCtD
Procainamide—Ill-defined disorder—Etoposide—brain cancer	0.000286	0.00408	CcSEcCtD
Procainamide—Decreased appetite—Carmustine—brain cancer	0.000283	0.00404	CcSEcCtD
Procainamide—Malaise—Etoposide—brain cancer	0.000278	0.00397	CcSEcCtD
Procainamide—SLC22A3—brain—brain cancer	0.000278	0.00299	CbGeAlD
Procainamide—Diarrhoea—Hydroxyurea—brain cancer	0.000276	0.00393	CcSEcCtD
Procainamide—BCHE—endocrine gland—brain cancer	0.000275	0.00296	CbGeAlD
Procainamide—Decreased appetite—Temozolomide—brain cancer	0.000274	0.0039	CcSEcCtD
Procainamide—BCHE—head—brain cancer	0.000272	0.00292	CbGeAlD
Procainamide—Feeling abnormal—Carmustine—brain cancer	0.000268	0.00383	CcSEcCtD
Procainamide—Convulsion—Etoposide—brain cancer	0.000267	0.00381	CcSEcCtD
Procainamide—Dizziness—Hydroxyurea—brain cancer	0.000266	0.0038	CcSEcCtD
Procainamide—Gastrointestinal pain—Carmustine—brain cancer	0.000266	0.0038	CcSEcCtD
Procainamide—Discomfort—Etoposide—brain cancer	0.00026	0.0037	CcSEcCtD
Procainamide—Feeling abnormal—Temozolomide—brain cancer	0.000259	0.0037	CcSEcCtD
Procainamide—Body temperature increased—Carmustine—brain cancer	0.000258	0.00367	CcSEcCtD
Procainamide—Abdominal pain—Carmustine—brain cancer	0.000258	0.00367	CcSEcCtD
Procainamide—Gastrointestinal pain—Temozolomide—brain cancer	0.000257	0.00367	CcSEcCtD
Procainamide—Vomiting—Hydroxyurea—brain cancer	0.000256	0.00365	CcSEcCtD
Procainamide—Confusional state—Etoposide—brain cancer	0.000254	0.00362	CcSEcCtD
Procainamide—Urticaria—Temozolomide—brain cancer	0.00025	0.00357	CcSEcCtD
Procainamide—SLC22A5—cerebellum—brain cancer	0.000249	0.00267	CbGeAlD
Procainamide—Body temperature increased—Temozolomide—brain cancer	0.000249	0.00355	CcSEcCtD
Procainamide—Abdominal pain—Temozolomide—brain cancer	0.000249	0.00355	CcSEcCtD
Procainamide—BCHE—central nervous system—brain cancer	0.000248	0.00267	CbGeAlD
Procainamide—Thrombocytopenia—Etoposide—brain cancer	0.000247	0.00352	CcSEcCtD
Procainamide—BCHE—cerebellum—brain cancer	0.000242	0.00261	CbGeAlD
Procainamide—Anorexia—Etoposide—brain cancer	0.00024	0.00342	CcSEcCtD
Procainamide—Hypersensitivity—Carmustine—brain cancer	0.00024	0.00342	CcSEcCtD
Procainamide—Nausea—Hydroxyurea—brain cancer	0.000239	0.00341	CcSEcCtD
Procainamide—Hypotension—Etoposide—brain cancer	0.000235	0.00336	CcSEcCtD
Procainamide—Asthenia—Carmustine—brain cancer	0.000234	0.00333	CcSEcCtD
Procainamide—Hypersensitivity—Temozolomide—brain cancer	0.000232	0.00331	CcSEcCtD
Procainamide—Asthenia—Temozolomide—brain cancer	0.000226	0.00322	CcSEcCtD
Procainamide—Diarrhoea—Carmustine—brain cancer	0.000223	0.00318	CcSEcCtD
Procainamide—Pruritus—Temozolomide—brain cancer	0.000223	0.00318	CcSEcCtD
Procainamide—Decreased appetite—Etoposide—brain cancer	0.000219	0.00312	CcSEcCtD
Procainamide—Dizziness—Carmustine—brain cancer	0.000215	0.00307	CcSEcCtD
Procainamide—Diarrhoea—Temozolomide—brain cancer	0.000215	0.00307	CcSEcCtD
Procainamide—Dizziness—Temozolomide—brain cancer	0.000208	0.00297	CcSEcCtD
Procainamide—Feeling abnormal—Etoposide—brain cancer	0.000208	0.00296	CcSEcCtD
Procainamide—Vomiting—Carmustine—brain cancer	0.000207	0.00295	CcSEcCtD
Procainamide—Gastrointestinal pain—Etoposide—brain cancer	0.000206	0.00294	CcSEcCtD
Procainamide—SLC22A5—brain—brain cancer	0.000202	0.00217	CbGeAlD
Procainamide—Vomiting—Temozolomide—brain cancer	0.0002	0.00285	CcSEcCtD
Procainamide—Urticaria—Etoposide—brain cancer	0.0002	0.00285	CcSEcCtD
Procainamide—Abdominal pain—Etoposide—brain cancer	0.000199	0.00284	CcSEcCtD
Procainamide—Body temperature increased—Etoposide—brain cancer	0.000199	0.00284	CcSEcCtD
Procainamide—BCHE—brain—brain cancer	0.000197	0.00212	CbGeAlD
Procainamide—Nausea—Carmustine—brain cancer	0.000194	0.00276	CcSEcCtD
Procainamide—Nausea—Temozolomide—brain cancer	0.000187	0.00267	CcSEcCtD
Procainamide—Hypersensitivity—Etoposide—brain cancer	0.000186	0.00265	CcSEcCtD
Procainamide—CYP2D6—endocrine gland—brain cancer	0.000182	0.00196	CbGeAlD
Procainamide—Asthenia—Etoposide—brain cancer	0.000181	0.00258	CcSEcCtD
Procainamide—CYP2D6—head—brain cancer	0.00018	0.00193	CbGeAlD
Procainamide—Pruritus—Etoposide—brain cancer	0.000178	0.00254	CcSEcCtD
Procainamide—Diarrhoea—Etoposide—brain cancer	0.000172	0.00246	CcSEcCtD
Procainamide—Dizziness—Etoposide—brain cancer	0.000167	0.00237	CcSEcCtD
Procainamide—CYP2D6—central nervous system—brain cancer	0.000164	0.00177	CbGeAlD
Procainamide—CYP2D6—cerebellum—brain cancer	0.000161	0.00173	CbGeAlD
Procainamide—Vomiting—Etoposide—brain cancer	0.00016	0.00228	CcSEcCtD
Procainamide—Nausea—Etoposide—brain cancer	0.00015	0.00213	CcSEcCtD
Procainamide—CYP2D6—brain—brain cancer	0.00013	0.0014	CbGeAlD
Procainamide—SCN1A—L1CAM interactions—EGFR—brain cancer	5.05e-05	0.00306	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	5.04e-05	0.00305	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—CYP2C9—brain cancer	4.86e-05	0.00294	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	4.79e-05	0.0029	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—HES1—brain cancer	4.78e-05	0.0029	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—ERBB2—brain cancer	4.71e-05	0.00286	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CDK4—brain cancer	4.6e-05	0.00279	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.55e-05	0.00276	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—PTCH2—brain cancer	4.26e-05	0.00258	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—ERBB2—brain cancer	4.2e-05	0.00255	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	4.16e-05	0.00252	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	4.14e-05	0.00251	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—CDK4—brain cancer	4.1e-05	0.00249	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—TRPC6—brain cancer	4.06e-05	0.00246	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.06e-05	0.00246	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	4.06e-05	0.00246	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—ESR2—brain cancer	4.02e-05	0.00244	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	4.01e-05	0.00243	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	3.87e-05	0.00235	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—HES1—brain cancer	3.87e-05	0.00234	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—ERBB2—brain cancer	3.84e-05	0.00233	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—VAV1—brain cancer	3.77e-05	0.00228	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CDK4—brain cancer	3.75e-05	0.00227	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—CTNNB1—brain cancer	3.75e-05	0.00227	CbGpPWpGaD
Procainamide—ACHE—Phospholipid metabolism—PIK3CG—brain cancer	3.74e-05	0.00227	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TRPC6—brain cancer	3.74e-05	0.00227	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—OR4C12—brain cancer	3.73e-05	0.00226	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—OR14C36—brain cancer	3.73e-05	0.00226	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.72e-05	0.00226	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—HES1—brain cancer	3.7e-05	0.00224	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—VEGFA—brain cancer	3.63e-05	0.0022	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—HES1—brain cancer	3.55e-05	0.00215	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—HES1—brain cancer	3.55e-05	0.00215	CbGpPWpGaD
Procainamide—SCN5A—L1CAM interactions—EGFR—brain cancer	3.55e-05	0.00215	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.55e-05	0.00215	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—HES1—brain cancer	3.43e-05	0.00208	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—HES1—brain cancer	3.43e-05	0.00208	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—OR4C12—brain cancer	3.39e-05	0.00206	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—OR14C36—brain cancer	3.39e-05	0.00206	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—RELA—brain cancer	3.38e-05	0.00205	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—ERBB2—brain cancer	3.36e-05	0.00204	CbGpPWpGaD
Procainamide—BCHE—Peptide hormone metabolism—CTNNB1—brain cancer	3.34e-05	0.00203	CbGpPWpGaD
Procainamide—BCHE—Phospholipid metabolism—PIK3CG—brain cancer	3.34e-05	0.00203	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.32e-05	0.00202	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—EGFR—brain cancer	3.26e-05	0.00198	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—VEGFA—brain cancer	3.23e-05	0.00196	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—HES1—brain cancer	3.12e-05	0.00189	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—ERBB2—brain cancer	3.11e-05	0.00188	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—PDGFRA—brain cancer	3.09e-05	0.00187	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	3.07e-05	0.00186	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.06e-05	0.00186	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	3.05e-05	0.00185	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	3.04e-05	0.00184	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CDK4—brain cancer	3.03e-05	0.00184	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—RELA—brain cancer	3.01e-05	0.00183	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—ERBB2—brain cancer	3e-05	0.00182	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—ERBB2—brain cancer	2.97e-05	0.0018	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.97e-05	0.0018	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—VEGFA—brain cancer	2.96e-05	0.00179	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CTNNB1—brain cancer	2.94e-05	0.00178	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—ESR2—brain cancer	2.93e-05	0.00177	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—EGFR—brain cancer	2.91e-05	0.00176	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CDK4—brain cancer	2.9e-05	0.00176	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.89e-05	0.00175	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—ERBB2—brain cancer	2.85e-05	0.00173	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—ERBB2—brain cancer	2.85e-05	0.00173	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CDK4—brain cancer	2.79e-05	0.00169	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CDK4—brain cancer	2.79e-05	0.00169	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NOTCH2—brain cancer	2.77e-05	0.00168	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—RELA—brain cancer	2.76e-05	0.00167	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—ERBB2—brain cancer	2.75e-05	0.00167	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—ERBB2—brain cancer	2.75e-05	0.00167	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—ERBB2—brain cancer	2.74e-05	0.00166	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CDK4—brain cancer	2.69e-05	0.00163	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CDK4—brain cancer	2.69e-05	0.00163	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—VEGFA—brain cancer	2.67e-05	0.00162	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—EGFR—brain cancer	2.66e-05	0.00161	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—CTNNB1—brain cancer	2.62e-05	0.00159	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—VEGFA—brain cancer	2.59e-05	0.00157	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP2C9—brain cancer	2.57e-05	0.00156	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—STAT3—brain cancer	2.56e-05	0.00155	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—HES1—brain cancer	2.41e-05	0.00146	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CTNNB1—brain cancer	2.4e-05	0.00145	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—APC—brain cancer	2.39e-05	0.00145	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CG—brain cancer	2.39e-05	0.00145	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—VEGFA—brain cancer	2.39e-05	0.00145	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—SIRT1—brain cancer	2.36e-05	0.00143	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—EGFR—brain cancer	2.33e-05	0.00141	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—VEGFA—brain cancer	2.31e-05	0.0014	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—VEGFA—brain cancer	2.29e-05	0.00139	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—STAT3—brain cancer	2.28e-05	0.00139	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	2.24e-05	0.00136	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—RELA—brain cancer	2.23e-05	0.00135	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—ERBB2—brain cancer	2.22e-05	0.00134	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—VEGFA—brain cancer	2.2e-05	0.00133	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—VEGFA—brain cancer	2.2e-05	0.00133	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—SHH—brain cancer	2.19e-05	0.00133	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—BSG—brain cancer	2.19e-05	0.00133	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PTCH2—brain cancer	2.18e-05	0.00132	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—EGFR—brain cancer	2.15e-05	0.00131	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—RELA—brain cancer	2.13e-05	0.00129	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—ERBB2—brain cancer	2.12e-05	0.00129	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—VEGFA—brain cancer	2.12e-05	0.00129	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—VEGFA—brain cancer	2.12e-05	0.00129	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—VEGFA—brain cancer	2.11e-05	0.00128	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—STAT3—brain cancer	2.09e-05	0.00127	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—PTCH1—brain cancer	2.08e-05	0.00126	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—SMO—brain cancer	2.08e-05	0.00126	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EGFR—brain cancer	2.08e-05	0.00126	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—EGFR—brain cancer	2.06e-05	0.00125	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—RELA—brain cancer	2.05e-05	0.00124	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—RELA—brain cancer	2.05e-05	0.00124	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—ERBB2—brain cancer	2.04e-05	0.00123	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—ERBB2—brain cancer	2.04e-05	0.00123	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP2C9—brain cancer	2.02e-05	0.00123	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OR4C12—brain cancer	2e-05	0.00121	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—OR14C36—brain cancer	2e-05	0.00121	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.98e-05	0.0012	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—EGFR—brain cancer	1.98e-05	0.0012	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—EGFR—brain cancer	1.98e-05	0.0012	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—RELA—brain cancer	1.98e-05	0.0012	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—RELA—brain cancer	1.98e-05	0.0012	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—ERBB2—brain cancer	1.96e-05	0.00119	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—ERBB2—brain cancer	1.96e-05	0.00119	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.96e-05	0.00119	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CTNNB1—brain cancer	1.94e-05	0.00118	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—ERBB2—brain cancer	1.93e-05	0.00117	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	1.92e-05	0.00116	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—EGFR—brain cancer	1.91e-05	0.00116	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—EGFR—brain cancer	1.91e-05	0.00116	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EGFR—brain cancer	1.9e-05	0.00115	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CDK4—brain cancer	1.89e-05	0.00115	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ABR—brain cancer	1.89e-05	0.00114	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—IDH1—brain cancer	1.88e-05	0.00114	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CTNNB1—brain cancer	1.85e-05	0.00112	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP2C9—brain cancer	1.81e-05	0.0011	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.79e-05	0.00108	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CTNNB1—brain cancer	1.78e-05	0.00108	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CTNNB1—brain cancer	1.78e-05	0.00108	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.73e-05	0.00105	CbGpPWpGaD
Procainamide—ACHE—Metabolism—BSG—brain cancer	1.72e-05	0.00104	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CTNNB1—brain cancer	1.72e-05	0.00104	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CTNNB1—brain cancer	1.72e-05	0.00104	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ABR—brain cancer	1.71e-05	0.00104	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—VEGFA—brain cancer	1.71e-05	0.00103	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DTX2—brain cancer	1.7e-05	0.00103	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—STAT3—brain cancer	1.69e-05	0.00102	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—VEGFA—brain cancer	1.63e-05	0.00099	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—STAT3—brain cancer	1.62e-05	0.00098	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP2C9—brain cancer	1.61e-05	0.000978	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.59e-05	0.000963	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VEGFA—brain cancer	1.57e-05	0.000951	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VEGFA—brain cancer	1.57e-05	0.000951	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	1.57e-05	0.00095	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.55e-05	0.000942	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—STAT3—brain cancer	1.55e-05	0.000942	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—STAT3—brain cancer	1.55e-05	0.000942	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EGFR—brain cancer	1.54e-05	0.000931	CbGpPWpGaD
Procainamide—BCHE—Metabolism—BSG—brain cancer	1.54e-05	0.000931	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—brain cancer	1.51e-05	0.000917	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—brain cancer	1.51e-05	0.000917	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP2C9—brain cancer	1.5e-05	0.000912	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—STAT3—brain cancer	1.5e-05	0.000908	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—STAT3—brain cancer	1.5e-05	0.000908	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—brain cancer	1.49e-05	0.000904	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ENO2—brain cancer	1.49e-05	0.000902	CbGpPWpGaD
Procainamide—ACHE—Metabolism—IDH1—brain cancer	1.48e-05	0.000898	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EGFR—brain cancer	1.47e-05	0.000891	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EGFR—brain cancer	1.41e-05	0.000856	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EGFR—brain cancer	1.41e-05	0.000856	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—RELA—brain cancer	1.39e-05	0.000842	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—ERBB2—brain cancer	1.38e-05	0.000837	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	1.38e-05	0.000836	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—BSG—brain cancer	1.37e-05	0.000832	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EGFR—brain cancer	1.36e-05	0.000825	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EGFR—brain cancer	1.36e-05	0.000825	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—EGFR—brain cancer	1.34e-05	0.000813	CbGpPWpGaD
Procainamide—BCHE—Metabolism—IDH1—brain cancer	1.32e-05	0.000801	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.3e-05	0.000791	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTCH2—brain cancer	1.29e-05	0.000783	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.29e-05	0.000781	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—BSG—brain cancer	1.28e-05	0.000775	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HES5—brain cancer	1.25e-05	0.000758	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STRADA—brain cancer	1.21e-05	0.000736	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CTNNB1—brain cancer	1.21e-05	0.000732	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.21e-05	0.000731	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	1.2e-05	0.000725	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—IDH1—brain cancer	1.18e-05	0.000715	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ENO2—brain cancer	1.17e-05	0.00071	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—SHH—brain cancer	1.13e-05	0.000682	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—IDH1—brain cancer	1.1e-05	0.000667	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TRPC6—brain cancer	1.09e-05	0.000658	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.08e-05	0.000652	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PTCH1—brain cancer	1.07e-05	0.000647	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—SMO—brain cancer	1.07e-05	0.000647	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—brain cancer	1.06e-05	0.000645	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—STAT3—brain cancer	1.05e-05	0.000638	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ENO2—brain cancer	1.04e-05	0.000633	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ABR—brain cancer	1.01e-05	0.000614	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GLI2—brain cancer	9.78e-06	0.000593	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EGFR—brain cancer	9.57e-06	0.00058	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ENO2—brain cancer	9.33e-06	0.000565	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—MYC—brain cancer	9.23e-06	0.00056	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GLI1—brain cancer	9.2e-06	0.000558	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—VAV1—brain cancer	8.95e-06	0.000543	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SUFU—brain cancer	8.72e-06	0.000529	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ENO2—brain cancer	8.69e-06	0.000527	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—GFAP—brain cancer	8.41e-06	0.00051	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP2C9—brain cancer	8.31e-06	0.000504	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—VAV1—brain cancer	8.13e-06	0.000493	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HEY1—brain cancer	7.97e-06	0.000483	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—DLL1—brain cancer	7.82e-06	0.000474	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CTNNB1—brain cancer	7.08e-06	0.000429	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—BSG—brain cancer	7.06e-06	0.000428	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CG—brain cancer	6.82e-06	0.000414	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SHH—brain cancer	6.65e-06	0.000403	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TRPC6—brain cancer	6.41e-06	0.000389	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CTNNB1—brain cancer	6.31e-06	0.000383	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTCH1—brain cancer	6.3e-06	0.000382	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SMO—brain cancer	6.3e-06	0.000382	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—IDH1—brain cancer	6.07e-06	0.000368	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	5.69e-06	0.000345	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CG—brain cancer	5.37e-06	0.000326	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	5.16e-06	0.000313	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOTCH2—brain cancer	5.04e-06	0.000306	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VAV1—brain cancer	4.8e-06	0.000291	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ENO2—brain cancer	4.8e-06	0.000291	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CG—brain cancer	4.79e-06	0.00029	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CG—brain cancer	4.28e-06	0.000259	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HES1—brain cancer	4.13e-06	0.00025	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—IL2—brain cancer	4e-06	0.000243	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CG—brain cancer	3.99e-06	0.000242	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDGFRA—brain cancer	3.93e-06	0.000238	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SPP1—brain cancer	3.82e-06	0.000232	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL2—brain cancer	3.63e-06	0.00022	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IRS2—brain cancer	3.45e-06	0.000209	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—APC—brain cancer	3.05e-06	0.000185	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CG—brain cancer	3.05e-06	0.000185	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—brain cancer	2.78e-06	0.000168	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RELA—brain cancer	2.38e-06	0.000144	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ERBB2—brain cancer	2.37e-06	0.000144	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CG—brain cancer	2.2e-06	0.000134	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL2—brain cancer	2.15e-06	0.00013	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCND1—brain cancer	2.09e-06	0.000127	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CTNNB1—brain cancer	2.07e-06	0.000126	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—brain cancer	1.82e-06	0.000111	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STAT3—brain cancer	1.81e-06	0.00011	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MYC—brain cancer	1.68e-06	0.000102	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—brain cancer	1.64e-06	9.95e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—brain cancer	1.38e-06	8.36e-05	CbGpPWpGaD
